| OCULAR THERAPEUT.DL-,0001 |
| USA |
| Gesundheit |
| US67576A1007 / A1180P |
| 0OT (Frankfurt) / OCUL (NASDAQ) |
| FRA:0OT, ETR:0OT, 0OT:GR, NASDAQ:OCUL |
| - |
| https://www.ocutx.com/ |
|
Ocular Therapeutix Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for diseases and conditions of the eye. The company's primary focus..
>Volltext.. |
| 1647.32 Mio. EUR |
| 1086.2 Mio. EUR |
| 43.97 Mio. EUR |
| -224.89 Mio. EUR |
| -225.1 Mio. EUR |
| -1.22 EUR |
| 65.15 Mio. EUR |
| 623.88 Mio. EUR |
| -173.42 Mio. EUR |
| 14.51 |
| -28.14% |
| -21.13% |
| - |
| - |
| - |
| OCULAR THERAPEUTIX, OCULAR THERA |
| 02.03.26 |
|